stars 1 stars 2 stars 3

iFAST is developing a game-changing, rapid antimicrobial susceptibility test, that will enable every patient with bacterial infections to receive the right antibiotic, on time, every time. Currently, these tests take 48-72 hours, but iFAST's tests are 10x faster - giving full quantitative and qualitative results in under 3 hours from a positive blood culture or bacterial isolate. The technology is cheaper and involve less tedious manual labour than current standard of care, which is based on technology from the mid-1900s! We also offer high throughout (most labs only need one system to accommodate all their requirements). This is a $4bn market and we will be launching on the UK market at the start of 2026, and in the US and EU the following year.

iFAST Diagnostics Questions

Toby King is the CEO of iFAST Diagnostics.

17 people are employed at iFAST Diagnostics.

iFAST Diagnostics is based in Southampton, England.

Top iFAST Diagnostics Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users